Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

China Biologic Products Inc Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 Net Income Guidance


Tuesday, 5 Nov 2013 05:00pm EST 

China Biologic Products Inc announced that for fiscal 2013, it expects to meet the high end of its total sales forecast range of $195 million to $205 million and non-GAAP adjusted net income estimate to the range of $58 million to $60 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $202 million for fiscal 2013. 

Company Quote

46.17
-1.59 -3.33%
22 Jul 2014